ch14.18/CHO Bridging Study

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

March 31, 2012

Conditions
Neuroblastoma
Interventions
DRUG

ch14.18/CHO

Trial Locations (3)

1090

St Anna Kinderspital, Vienna

13353

Charite Children's Hospital, Berlin

16147

Gaslini Children's Hospital, Genova

All Listed Sponsors
collaborator

St. Anna Children's Hospital, Vienna

UNKNOWN

collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Istituto Giannina Gaslini

OTHER

lead

St. Anna Kinderkrebsforschung

OTHER

NCT01704872 - ch14.18/CHO Bridging Study | Biotech Hunter | Biotech Hunter